Literature DB >> 2157878

Inhibition of lymphoproliferation and protein kinase C by synthetic peptides with sequence identity to the transmembrane and Q proteins of visna virus.

C L Ruegg1, J E Clements, M Strand.   

Abstract

A peptide sequence in the transmembrane protein of visna virus has been identified that bears a high degree of similarity to a sequence within the transmembrane protein gp41 of human immunodeficiency virus that we have previously shown to be immunosuppressive. Also within the Q (vif/sor) open reading frame of the visna virus genome is a sequence that is highly similar to the immunosuppressive sequence from the retroviral transmembrane protein p15E. We synthesized peptides containing these visna virus sequences and tested them for immunosuppressive activity, comparing them with their human immunodeficiency virus and leukemia retrovirus counterparts. Both the Q- and transmembrane-derived visna virus peptides inhibited lymphoproliferation stimulated by either interleukin-2 or the T-cell antigen receptor in a dose-dependent and sequence-specific manner. The two visna virus peptides also inhibited the enzymatic activity of protein kinase C, thus providing a possible molecular mechanism by which they inhibit immune function.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157878      PMCID: PMC249376          DOI: 10.1128/JVI.64.5.2175-2180.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.

Authors:  P Sonigo; M Alizon; K Staskus; D Klatzmann; S Cole; O Danos; E Retzel; P Tiollais; A Haase; S Wain-Hobson
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.

Authors:  G J Cianciolo; T D Copeland; S Oroszlan; R Snyderman
Journal:  Science       Date:  1985-10-25       Impact factor: 47.728

Review 3.  Lentiviral diseases of sheep and goats: chronic pneumonia leukoencephalomyelitis and arthritis.

Authors:  O Narayan; L C Cork
Journal:  Rev Infect Dis       Date:  1985 Jan-Feb

4.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

5.  Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites.

Authors:  D H Gabuzda; J L Hess; J A Small; J E Clements
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

6.  Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.

Authors:  J Alcocer-Varela; D Alarcón-Segovia
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

7.  Purified rat brain calcium- and phospholipid-dependent protein kinase phosphorylates ribosomal protein S6.

Authors:  C J Le Peuch; R Ballester; O M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

8.  Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow.

Authors:  H E Gendelman; O Narayan; S Molineaux; J E Clements; Z Ghotbi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  T cell activation: differences in the signals required for IL 2 production by nonactivated and activated T cells.

Authors:  B Manger; A Weiss; C Weyand; J Goronzy; J D Stobo
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  Restricted replication of lentiviruses. Visna viruses induce a unique interferon during interaction between lymphocytes and infected macrophages.

Authors:  O Narayan; D Sheffer; J E Clements; G Tennekoon
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  1 in total

1.  The restricted IgG1 antibody response to maedi visna virus is seen following infection but not following immunization with recombinant gag protein.

Authors:  P Bird; H T Reyburn; B A Blacklaws; D Allen; P Nettleton; D L Yirrell; N Watt; D Sargan; I McConnell
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.